News-Zhongshan Laibo Ruichen Biomedicine Co., Ltd.

16984638634831788

News

v2-61f4602ae0e0db137524df3557bbfdfc_720w

Rabpharma Successfully Recognized as a National High-tech Enterprise

45b598335b66314cecbd3862d162dec9

Rabpharma's RAB001 Secures Additional IND Clearance, Expanding into Osteoarthritis

调亮了d6112(1)(1)(1)(1)

Patient enrollment has been completed for the RAB001 Phase II clinical trial!

IMG_8184(1)

Rabpharma Successfully Closes Oversubscribed Series A++ Funding Round to Accelerate R&D Progress

17504044479908368(1)

Early-Stage Osteonecrosis Phase II Clinical Trial Patient Recruitment

1 2 3 4 5

info@rabpharma.com